Literature DB >> 17253767

Surface plasmon resonance and nuclear magnetic resonance studies of ABAD-Abeta interaction.

Yilin Yan1, Yangzhong Liu, Mirco Sorci, Georges Belfort, Joyce W Lustbader, Shirley ShiDu Yan, Chunyu Wang.   

Abstract

Abeta binding alcohol dehydrogenase (ABAD) is an NAD-dependent mitochondrial dehydrogenase. The binding between ABAD and Abeta is likely a direct link between Abeta and mitochondrial toxicity in Alzheimer's disease. In this study, surface plasmon resonance (SPR) was employed to determine the temperature dependence of the affinity of the ABAD-Abeta interaction. A van't Hoff analysis revealed that the ABAD-Abeta association is driven by a favorable entropic change (DeltaS = 300 +/- 30 J mol-1 K-1) which overcomes an unfavorable enthalpy change (DeltaH = 49 +/- 7 kJ/mol). Therefore, hydrophobic interactions and changes in protein dynamics are the dominant driving forces of the ABAD-Abeta interaction. This is the first dissection of the entropic and enthalpic contribution to the energetics of a protein-protein interaction involving Abeta. SPR confirmed the conformational changes in the ABAD-Abeta complex after Abeta binding, consistent with differences seen in the crystal structures of free ABAD and the ABAD-Abeta complex. Saturation transfer difference (STD) NMR experiments directly and unambiguously demonstrated the inhibitory effect of Abeta on the ABAD-NAD interaction. Conversely, NAD inhibits the Abeta-ABAD interaction. Binding of Abeta and binding of NAD to ABAD are likely mutually exclusive. Thus, Abeta binding induces conformational and subsequently functional changes in ABAD, which may have a role in the mechanism of Abeta toxicity in Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17253767     DOI: 10.1021/bi061314n

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  25 in total

1.  Microglial receptor for advanced glycation end product-dependent signal pathway drives beta-amyloid-induced synaptic depression and long-term depression impairment in entorhinal cortex.

Authors:  Nicola Origlia; Camilla Bonadonna; Alfredo Rosellini; Elena Leznik; Ottavio Arancio; Shirley Shidu Yan; Luciano Domenici
Journal:  J Neurosci       Date:  2010-08-25       Impact factor: 6.167

2.  Stoichiometry and affinity of the human serum albumin-Alzheimer's Aβ peptide interactions.

Authors:  Julijana Milojevic; Giuseppe Melacini
Journal:  Biophys J       Date:  2011-01-05       Impact factor: 4.033

3.  Determination of small molecule ABAD inhibitors crossing blood-brain barrier and pharmacokinetics.

Authors:  Jhansi Rani Vangavaragu; Koteswara Rao Valasani; Du Fang; Todd D Williams; Shirley ShiDu Yan
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

4.  Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer's disease.

Authors:  Heng Du; Lan Guo; Fang Fang; Doris Chen; Alexander A Sosunov; Guy M McKhann; Yilin Yan; Chunyu Wang; Hong Zhang; Jeffery D Molkentin; Frank J Gunn-Moore; Jean Paul Vonsattel; Ottavio Arancio; John Xi Chen; Shi Du Yan
Journal:  Nat Med       Date:  2008-09-21       Impact factor: 53.440

Review 5.  Is amyloid binding alcohol dehydrogenase a drug target for treating Alzheimer's disease?

Authors:  Eva Borger; Laura Aitken; Heng Du; Wenshen Zhang; Frank J Gunn-Moore; Shirley Shi Du Yan
Journal:  Curr Alzheimer Res       Date:  2013-01       Impact factor: 3.498

6.  Phenolic compounds prevent amyloid β-protein oligomerization and synaptic dysfunction by site-specific binding.

Authors:  Kenjiro Ono; Lei Li; Yusaku Takamura; Yuji Yoshiike; Lijun Zhu; Fang Han; Xian Mao; Tokuhei Ikeda; Jun-ichi Takasaki; Hisao Nishijo; Akihiko Takashima; David B Teplow; Michael G Zagorski; Masahito Yamada
Journal:  J Biol Chem       Date:  2012-03-05       Impact factor: 5.157

7.  RAGE inhibition in microglia prevents ischemia-dependent synaptic dysfunction in an amyloid-enriched environment.

Authors:  Nicola Origlia; Chiara Criscuolo; Ottavio Arancio; Shirley ShiDu Yan; Luciano Domenici
Journal:  J Neurosci       Date:  2014-06-25       Impact factor: 6.167

8.  Oligomeric and fibrillar species of beta-amyloid (A beta 42) both impair mitochondrial function in P301L tau transgenic mice.

Authors:  Anne Eckert; Susanne Hauptmann; Isabel Scherping; Jessica Meinhardt; Virginie Rhein; Stefan Dröse; Ulrich Brandt; Marcus Fändrich; Walter E Müller; Jürgen Götz
Journal:  J Mol Med (Berl)       Date:  2008-08-16       Impact factor: 4.599

9.  Stable expression of a novel fusion peptide of thioredoxin-1 and ABAD-inhibiting peptide protects PC12 cells from intracellular amyloid-beta.

Authors:  Xin Yang; Yu Yang; Jiang Wu; Jie Zhu
Journal:  J Mol Neurosci       Date:  2007       Impact factor: 3.444

10.  An update on the toxicity of Abeta in Alzheimer's disease.

Authors:  Jürgen Götz; Lars M Ittner; Nicole Schonrock; Roberto Cappai
Journal:  Neuropsychiatr Dis Treat       Date:  2008-12       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.